Gadodiamide

钆双胺

Report date: 2022/08/16 20:00:19
NME

Base Information

Drug NameGadodiamide
Drug Alias Name轧双胺gadodiamidumgadodiamida钆双铵钇双胺 +[10] 
ClassificationSmall moleculesDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsContrast agentsArterial Occlusive DiseasesCoronary Artery Disease +[5] 
Global Approved IndicationsContrast agents
Approved Indications in ChinaContrast agents
Original Approved Country/TerritoryUnited States
Original Approved Date1993/01/08
Country/TerritoryUnited StatesGermanyMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGe Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesGe HealthcareNycomed Ireland Ltd
Inactive CompaniesAmersham Buchler, Gmbh & Co Kg
Active IndicationsContrast agents
Inactive IndicationsArterial Occlusive DiseasesCoronary Artery DiseaseRenal Artery Obstruction +[4] 

Other Information

ATC CodeV08CA03
Related LinksWikipediaDrugBankKEGG